Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer.
Andrew J ArmstrongSantosh GuptaPatrick HealyGabor KemenyBeth LeithMichael R ZalutskyCharles SpritzerCatrin DaviesColin RothwellKathryn WareJason A SomarelliKris WoodThomas RibarParaskevi GiannakakouJiaren ZhangDrew GerberMonika AnandWen-Chi FooSusan HalabiSimon G GregoryDaniel J GeorgePublished in: PloS one (2019)
Osteomimicry may contribute in part to the uptake of radium-223 within bone metastases and may thereby enhance the therapeutic benefit of this bone targeting radiotherapy.